EE03422B1 - Kompositsioonid IRDS ja ARDS raviks - Google Patents

Kompositsioonid IRDS ja ARDS raviks

Info

Publication number
EE03422B1
EE03422B1 EE9700084A EE9700084A EE03422B1 EE 03422 B1 EE03422 B1 EE 03422B1 EE 9700084 A EE9700084 A EE 9700084A EE 9700084 A EE9700084 A EE 9700084A EE 03422 B1 EE03422 B1 EE 03422B1
Authority
EE
Estonia
Prior art keywords
compositions
treatment
irds
ards
glucocorticosteroid
Prior art date
Application number
EE9700084A
Other languages
English (en)
Estonian (et)
Other versions
EE9700084A (et
Inventor
Germann Paul-Georg
Eistetter Klaus
Kilian Ulrich
H�fner Dietrich
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of EE9700084A publication Critical patent/EE9700084A/xx
Publication of EE03422B1 publication Critical patent/EE03422B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EE9700084A 1994-09-28 1995-09-27 Kompositsioonid IRDS ja ARDS raviks EE03422B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4434629A DE4434629C1 (de) 1994-09-28 1994-09-28 Zusammensetzungen zur Behandlung von IRDS und ARDS
PCT/EP1995/003816 WO1996009831A2 (de) 1994-09-28 1995-09-27 Zusammensetzungen zur behandlung von irds und ards, die mindestens ein glucocorticosteroid in kombination mit einem lungen surfactant enthalten

Publications (2)

Publication Number Publication Date
EE9700084A EE9700084A (et) 1997-10-15
EE03422B1 true EE03422B1 (et) 2001-06-15

Family

ID=6529394

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700084A EE03422B1 (et) 1994-09-28 1995-09-27 Kompositsioonid IRDS ja ARDS raviks

Country Status (26)

Country Link
US (1) US5891844A (ja)
EP (1) EP0783314B1 (ja)
JP (1) JP4425991B2 (ja)
KR (1) KR100365030B1 (ja)
CN (1) CN1100542C (ja)
AT (1) ATE241372T1 (ja)
AU (1) AU705099B2 (ja)
BG (1) BG62556B1 (ja)
CA (1) CA2201377C (ja)
CZ (1) CZ292846B6 (ja)
DE (2) DE4434629C1 (ja)
DK (1) DK0783314T3 (ja)
EE (1) EE03422B1 (ja)
ES (1) ES2201120T3 (ja)
FI (1) FI118886B (ja)
HK (1) HK1003869A1 (ja)
HU (1) HU226958B1 (ja)
MX (1) MX9702303A (ja)
NO (1) NO313405B1 (ja)
NZ (1) NZ294587A (ja)
PL (1) PL187496B1 (ja)
PT (1) PT783314E (ja)
RU (1) RU2157222C2 (ja)
SK (1) SK284446B6 (ja)
UA (1) UA43378C2 (ja)
WO (1) WO1996009831A2 (ja)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
HU227520B1 (hu) * 1997-02-17 2011-07-28 Nycomed Gmbh ARDS és IRDS kezelésére szolgáló, 3-(ciklopropil-metoxi)-N-(3,5-diklór-4-piridinil)-4-(difluor-metoxi)-benzamidot és tüdõfelületaktív anyagot tartalmazó kompozíció
US7122344B2 (en) 1997-05-28 2006-10-17 Claragen, Inc. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
CN1194833A (zh) * 1997-10-08 1998-10-07 刘柏宏 肺活素
US6858223B2 (en) 1998-06-23 2005-02-22 Altana Pharma Ag Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
CA2372558A1 (en) * 1999-06-11 2000-12-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
AU6083899A (en) * 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
SI1276495T1 (sl) * 2000-04-12 2006-10-31 Altana Pharma Ag Uporaba rekombinantnega pljucnega surfaktanta za zgodnje zdravljenje akutnih pljucnih bolezni
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
WO2001085136A2 (en) * 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
DE10132307A1 (de) * 2001-07-06 2003-01-30 Aventis Behring Gmbh Arzneizubereitung zur Inhalation von Antithrombin bei entzündlichen Lungenerkrankungen und ARDS
US20030099601A1 (en) * 2001-11-27 2003-05-29 Gordon Marc S. Inhalation lung surfactant therapy
US6998384B2 (en) * 2001-12-12 2006-02-14 The Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
MXPA04005865A (es) * 2001-12-19 2004-09-13 Nektar Therapeutics Suministro de aminoglucosidos a los pulmones.
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
CA2529007C (en) 2003-06-16 2012-03-27 Altana Pharma Ag Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
ES2452691T5 (es) * 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
CA2593758A1 (en) 2005-01-06 2006-07-13 Discovery Laboratories, Inc. Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
KR100891595B1 (ko) 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물
MX2009003002A (es) * 2006-09-19 2009-06-01 Discovery Lab Inc Formulaciones de tensioactivos pulmonares y metodos para promover la aclaracion del moco.
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
US9345716B2 (en) * 2010-12-10 2016-05-24 Indian Institute Of Technology, Bombay Protein free surfactant composition for pulmonary diseases and a process for preparing the same
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
CN106310280A (zh) * 2016-08-18 2017-01-11 滨州医学院 地瑞那韦增强糖皮质激素抗炎作用的医药新用途
CN110099695B (zh) * 2016-12-22 2022-01-25 奇斯药制品公司 用于治疗进展性bpd的包含肺表面活性物质和类固醇的治疗组合

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances

Also Published As

Publication number Publication date
CZ94097A3 (en) 1997-09-17
RU2157222C2 (ru) 2000-10-10
BG101441A (en) 1997-09-30
EE9700084A (et) 1997-10-15
CN1100542C (zh) 2003-02-05
ATE241372T1 (de) 2003-06-15
CA2201377A1 (en) 1996-04-04
SK40197A3 (en) 1998-02-04
JP4425991B2 (ja) 2010-03-03
FI971277A0 (fi) 1997-03-26
ES2201120T3 (es) 2004-03-16
NO313405B1 (no) 2002-09-30
EP0783314B1 (de) 2003-05-28
AU705099B2 (en) 1999-05-13
SK284446B6 (sk) 2005-04-01
UA43378C2 (uk) 2001-12-17
PT783314E (pt) 2003-10-31
JPH10506119A (ja) 1998-06-16
HUT77931A (hu) 1998-11-30
DE59510705D1 (de) 2003-07-03
FI971277A (fi) 1997-05-27
WO1996009831A3 (de) 1996-05-23
CA2201377C (en) 2008-07-29
HU226958B1 (en) 2010-03-29
CZ292846B6 (cs) 2003-12-17
NO971403D0 (no) 1997-03-25
WO1996009831A2 (de) 1996-04-04
PL319608A1 (en) 1997-08-18
EP0783314A2 (de) 1997-07-16
BG62556B1 (bg) 2000-02-29
PL187496B1 (pl) 2004-07-30
NZ294587A (en) 1998-07-28
AU3742895A (en) 1996-04-19
NO971403L (no) 1997-04-17
HK1003869A1 (en) 1998-11-13
KR970706006A (ko) 1997-11-03
DK0783314T3 (da) 2003-12-01
DE4434629C1 (de) 1996-06-27
US5891844A (en) 1999-04-06
FI118886B (fi) 2008-04-30
CN1163571A (zh) 1997-10-29
KR100365030B1 (ko) 2003-03-10
MX9702303A (es) 1997-06-28

Similar Documents

Publication Publication Date Title
EE03422B1 (et) Kompositsioonid IRDS ja ARDS raviks
DE68922314D1 (de) Synergetische brennstoffzusammensetzung.
NL193922B (nl) Voedingsbron met geschakelde modus.
FI910393A (fi) Semi-termoplastisk matriskomposition med vaermestabilt formbestaendigt minne.
EP0313305A3 (en) Photoprotection compositions comprising chelating agents
FI893127A0 (fi) Komposition som bildar en vattenavstoetande film.
DE69105462D1 (de) Desinfizierende Zusammensetzung.
DE3875300D1 (de) Turbo-verbundmaschine.
DE69107162D1 (de) Elektronenquelle mit teilchenhaltender Anordnung.
FI893206A0 (fi) Transportanordning.
DE69001295D1 (de) In zufuhranlage niederschlaege kontrollierende zusammensetzungen.
ES1025426Y (es) Frigorifico con entrepaño perfeccionado.
DE59702680D1 (de) Safranspirituose
LV10363A (lv) Sastavi ar fungicidu ipasibam
NO921807L (no) Brennstoffsammensetning
FI954743A (fi) Difluorimetoksi-2,2,2-trifluorietaania sisältävät koostumukset
FI914156A0 (fi) Kompositioner.
DE69112642D1 (de) Glutaminhaltige lyophilisierte aminokarbonsäurenzusammensetzungen.
IT8822296A0 (it) Composizione di combustibile ad elevato contenuto energetico.
DE3872764D1 (de) Tinten-zusammensetzungen und deren zubereitung.
DE59008045D1 (de) Zusammensetzungen mit Dichlormonofluorethanen.
DE69019395D1 (de) Zusammensetzung gegen Mikroben.
DK346387D0 (da) Fremgangsmaade til at reducere alkaliindholdet i cementklinker
KR920014720U (ko) 일시 차단장치를 갖는 샤위기
KR950010779U (ko) 송풍장치가 부착된 통풍이 되는 의자

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231